ANIXA BIOSCIENCES, INC. (ANIX) Shareholder Equity
- 2026-07-31: Common Stock, Value, IssuedUSD $346.00K; Additional Paid in CapitalUSD $273.49M; Treasury Stock, ValueUSD (m); Retained Earnings (Accumulated Deficit)USD $-259.36M.
- 2026-04-30: Common Stock, Value, IssuedUSD $339.00K; Additional Paid in CapitalUSD $270.89M; Treasury Stock, ValueUSD (m); Retained Earnings (Accumulated Deficit)USD $-256.76M.
- 2026-01-31: Common Stock, Value, IssuedUSD $335.00K; Additional Paid in CapitalUSD $268.98M; Treasury Stock, ValueUSD (m); Retained Earnings (Accumulated Deficit)USD $-254.24M.
- 2025-10-31: Common Stock, Value, IssuedUSD $330.00K; Additional Paid in CapitalUSD $266.51M; Treasury Stock, ValueUSD (m); Retained Earnings (Accumulated Deficit)USD $-251.68M.
ANIXA BIOSCIENCES, INC. Shareholder Equity
Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.
| Period end | Common Stock, Value, Issued USD | Additional Paid in Capital USD | Treasury Stock, Value USD | Retained Earnings (Accumulated Deficit) USD | Stockholders' Equity Attributable to Parent USD | Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest USD | Treasury Stock, Common, Shares shares | Treasury Stock, Value, Acquired, Cost Method USD | Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs USD | APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition USD | Treasury Stock Acquired, Average Cost Per Share USD/shares | Preferred Stock, Value, Issued USD | Additional Paid in Capital, Common Stock USD | Accumulated Other Comprehensive Income (Loss), Net of Tax USD | APIC, Share-based Payment Arrangement, Restricted Stock Unit, Increase for Cost Recognition USD | APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD | Adjustments to Additional Paid in Capital, Warrant Issued USD | Adjustments to Additional Paid in Capital, Other USD | Treasury Stock, Shares, Acquired shares | Noncontrolling Interest, Increase from Subsidiary Equity Issuance USD |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-07-31 | $346.00K | $273.49M | (m) | $-259.36M | $14.47M | $13.20M | 0.00 | (m) | (m) | 3 month · $637.00K 9 month · $2.04M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2026-04-30 | $339.00K | $270.89M | (m) | $-256.76M | $14.47M | $13.22M | 0.00 | (m) | (m) | 3 month · $637.00K 6 month · $1.41M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2026-01-31 | $335.00K | $268.98M | (m) | $-254.24M | $15.08M | $13.85M | 0.00 | (m) | (m) | 3 month · $768.00K | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-10-31 | $330.00K | $266.51M | (m) | $-251.68M | $15.16M | $13.95M | 2.00K | (m) | (m) | 12 month · $3.68M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-07-31 | $328.00K | $265.25M | (m) | $-248.98M | $16.59M | $15.41M | 0.00 | (m) | (m) | 3 month · $829.00K 9 month · $2.82M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-04-30 | $322.00K | $262.47M | (m) | $-246.72M | $16.07M | $14.91M | 0.00 | (m) | (m) | 3 month · $962.00K 6 month · $1.99M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-01-31 | $322.00K | $261.47M | $6.00K | $-243.93M | $17.85M | $16.71M | 2.00K | (m) | 3 month · $17.00K | 3 month · $1.03M | 3 month · 3.17 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-10-31 | $322.00K | $260.43M | $6.00K | $-240.75M | $20.00M | $18.89M | 2.00K | 12 month · $6.00K | (m) | 12 month · $4.42M | 12 month · 3.17 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-07-31 | $321.00K | $259.32M | (m) | $-237.87M | $21.77M | $20.69M | (m) | (m) | 3 month · $45.00K | 3 month · $1.09M 9 month · $3.44M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-04-30 | $320.00K | $257.89M | (m) | $-234.59M | $23.62M | $22.58M | (m) | (m) | (m) | 3 month · $1.24M 6 month · $2.35M | (m) | (m) | (m) | (m) | (m) | (m) | 3 month · $22.00K 6 month · $78.00K | (m) | (m) | (m) |
| 2024-01-31 | $318.00K | $255.74M | (m) | $-231.45M | $24.61M | $23.60M | (m) | (m) | (m) | 3 month · $1.11M | (m) | (m) | (m) | (m) | (m) | (m) | 3 month · $56.00K | (m) | (m) | (m) |
| 2023-10-31 | $311.00K | $252.22M | (m) | $-228.20M | $24.34M | $23.37M | 2.00K | (m) | (m) | 12 month · $4.42M | (m) | (m) | (m) | (m) | (m) | (m) | 12 month · $221.00K | (m) | (m) | (m) |
| 2023-07-31 | $310.00K | $250.72M | (m) | $-225.51M | $25.52M | $24.59M | (m) | (m) | (m) | 3 month · $1.15M 9 month · $3.27M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-04-30 | $310.00K | $249.50M | (m) | $-223.00M | $26.81M | $25.91M | (m) | (m) | (m) | 3 month · $1.16M 6 month · $2.11M | (m) | (m) | (m) | (m) | (m) | (m) | 3 month · $47.00K 6 month · $128.00K | (m) | (m) | (m) |
| 2023-01-31 | $309.00K | $248.19M | (m) | $-220.71M | $27.79M | $26.91M | (m) | (m) | (m) | 3 month · $957.00K | (m) | (m) | (m) | (m) | (m) | (m) | 3 month · $81.00K | (m) | (m) | (m) |
| 2022-10-31 | $309.00K | $247.12M | (m) | $-218.38M | $29.05M | $28.20M | (m) | (m) | (m) | 12 month · $6.00M | (m) | (m) | (m) | (m) | (m) | (m) | 12 month · $655.00K | (m) | (m) | (m) |
| 2022-07-31 | $307.00K | $246.30M | (m) | $-214.91M | $31.70M | $30.91M | (m) | (m) | (m) | 3 month · $1.33M 9 month · $4.93M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-04-30 | $302.00K | $244.03M | (m) | $-212.16M | $32.17M | $31.41M | (m) | (m) | (m) | 3 month · $1.46M 6 month · $3.60M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-01-31 | $301.00K | $242.28M | (m) | $-208.62M | $33.96M | $33.24M | (m) | (m) | (m) | 3 month · $2.13M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-10-31 | $301.00K | $239.93M | (m) | $-204.79M | $35.44M | $34.77M | (m) | (m) | (m) | 12 month · $7.50M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-07-31 | $299.50K | $236.94M | (m) | $-200.78M | $36.47M | $35.85M | (m) | (m) | (m) | 3 month · $3.05M 9 month · $4.80M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-04-30 | $314.50K | $233.74M | (m) | $-196.44M | $37.61M | $37.05M | (m) | (m) | (m) | 3 month · $881.00K 6 month · $1.76M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-01-31 | $261.79K | $207.38M | (m) | $-194.04M | $13.60M | $13.08M | (m) | (m) | (m) | 3 month · $875.00K | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-10-31 | $242.49K | $200.35M | (m) | $-191.84M | $8.76M | $8.26M | (m) | (m) | (m) | 12 month · $3.92M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-07-31 | $236.54K | $197.99M | (m) | $-189.61M | $8.62M | $8.14M | (m) | (m) | (m) | 3 month · $997.09K 9 month · $3.02M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-04-30 | $214.79K | $192.12M | (m) | $-187.05M | $5.29M | $4.82M | (m) | (m) | (m) | 3 month · $1.06M 6 month · $2.02M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-01-31 | $208.41K | $189.65M | (m) | $-184.41M | $5.44M | $5.00M | (m) | (m) | (m) | 3 month · $963.88K | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2019-10-31 | $203.32K | $186.85M | (m) | $-181.82M | $5.24M | $4.81M | (m) | (m) | (m) | 12 month · $3.56M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2019-07-31 | $201.63K | $185.33M | (m) | $-179.73M | $5.80M | $5.40M | (m) | (m) | (m) | 3 month · $784.25K 9 month · $2.81M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2019-04-30 | $200.05K | $183.93M | (m) | $-177.59M | $6.54M | $6.17M | (m) | (m) | (m) | 3 month · $805.10K 6 month · $2.02M | (m) | (m) | (m) | (m) | 6 month · $1.95M | (m) | (m) | (m) | (m) | (m) |
| 2019-01-31 | $194.70K | $180.34M | (m) | $-175.05M | $5.48M | $5.14M | (m) | (m) | (m) | 3 month · $1.22M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 3 month · $46.22K | (m) | (m) |
| 2018-10-31 | $189.09K | $175.42M | (m) | $-170.17M | $5.43M | $5.18M | (m) | (m) | (m) | 12 month · $5.72M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 12 month · $318.14K | (m) | 12 month · $64.66K |
| 2018-07-31 | $186.96K | $171.01M | (m) | $-164.87M | $6.33M | $6.16M | (m) | (m) | (m) | 3 month · $3.13M 9 month · $3.60M | (m) | (m) | (m) | (m) | (m) | (m) | 9 month · $57.05K | 9 month · $197.04K | (m) | 9 month · $64.66K |
| 2018-04-30 | $168.50K | $165.29M | (m) | $-159.39M | $6.07M | $6.02M | (m) | (m) | (m) | 6 month · $472.53K | (m) | (m) | (m) | (m) | (m) | 6 month · $126.15K | (m) | 6 month · $126.15K | (m) | 6 month · $64.66K |
| 2018-01-31 | $166.31K | $164.28M | (m) | $-158.01M | $6.44M | $6.40M | (m) | (m) | (m) | 3 month · $214.43K | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 3 month · $52.55K | (m) | 3 month · $64.66K |
| 2017-10-31 | $166.03K | $163.93M | (m) | $-156.17M | $7.92M | $7.92M | (m) | (m) | (m) | 12 month · $1.22M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 12 month · $3.30K | (m) | (m) |
| 2017-07-31 | $151.20K | $159.73M | (m) | $-154.39M | $5.49M | (m) | (m) | (m) | (m) | 9 month · $932.77K | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2017-04-30 | $116.95K | $156.07M | (m) | $-152.59M | $3.59M | (m) | (m) | (m) | (m) | 6 month · $451.65K | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2017-01-31 | $87.58K | $148.85M | (m) | $-152.75M | $-3.82M | (m) | (m) | (m) | (m) | 3 month · $259.74K | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2016-10-31 | $87.52K | $152.05M | (m) | $-151.17M | $987.48K | $987.48K | (m) | (m) | (m) | 12 month · $873.56K | (m) | $14.00K | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2016-07-31 | $87.48K | $151.73M | (m) | $-150.12M | $1.72M | (m) | (m) | (m) | (m) | 9 month · $570.19K | (m) | $14.00K | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2016-04-30 | $87.40K | $151.47M | (m) | $-149.01M | $2.56M | (m) | (m) | (m) | (m) | 6 month · $329.75K | (m) | $14.00K | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2016-01-31 | $87.31K | (m) | (m) | $-147.74M | $3.59M | (m) | (m) | (m) | (m) | 3 month · $112.50K | (m) | $14.00K | $151.23M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2015-10-31 | $87.25K | $151.10M | (m) | $-146.15M | $5.05M | (m) | (m) | (m) | (m) | 12 month · $2.68M | (m) | $14.00K | $151.10M | (m) | (m) | (m) | (m) | (m) | 12 month · 92.23K | (m) |
| 2015-07-31 | $87.21K | $150.75M | (m) | $-144.86M | $6.00M | (m) | (m) | (m) | (m) | 9 month · $2.34M | (m) | $14.00K | (m) | (m) | (m) | (m) | (m) | (m) | 9 month · 32.00K | (m) |
| 2015-04-30 | $2.19M | $147.71M | (m) | $-143.25M | $6.99M | (m) | (m) | (m) | (m) | 6 month · $1.56M | (m) | $350.00K | (m) | (m) | (m) | (m) | (m) | (m) | 6 month · 800.00K | (m) |
| 2015-01-31 | $2.20M | $146.73M | (m) | $-141.02M | $8.26M | (m) | (m) | (m) | (m) | 3 month · $491.78K | (m) | $350.00K | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2014-10-31 | $87.88K | $148.68M | (m) | $-144.77M | $4.01M | (m) | (m) | (m) | (m) | 12 month · $3.15M | (m) | $14.00K | $148.68M | (m) | (m) | 12 month · $2.13M | 12 month · $513.11K | (m) | (m) | (m) |
| 2014-07-31 | $2.37M | $144.44M | (m) | $-141.62M | $149.71K | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $-46.37K | (m) | 9 month · $1.56M | 9 month · $513.11K | (m) | (m) | (m) |
| 2014-04-30 | $2.19M | $140.21M | (m) | $-142.03M | $-4.85M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $-219.89K | (m) | 6 month · $989.41K | 6 month · $513.11K | (m) | (m) | (m) |
| 2014-01-31 | $2.11M | $136.21M | (m) | $-138.78M | $-5.67M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $-210.91K | (m) | 3 month · $465.52K | 3 month · $513.11K | (m) | (m) | (m) |
| 2013-10-31 | $2.09M | $134.75M | (m) | $-135.16M | $-3.32M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 12 month · $2.69M | 12 month · $221.99K | (m) | (m) | (m) |
| 2013-07-31 | $2.06M | $133.05M | (m) | $-132.24M | $-3.24M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $-1.11M | (m) | 9 month · $2.12M | 9 month · $221.99K | (m) | (m) | (m) |
| 2013-04-30 | $2.00M | $130.57M | (m) | $-129.65M | $-1.45M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $638.73K | (m) | 6 month · $1.03M | 6 month · $221.99K | (m) | (m) | (m) |
| 2013-01-31 | $1.85M | $128.65M | (m) | $-127.18M | $-1.32M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $348.53K | (m) | 3 month · $473.27K | 3 month · $221.99K | (m) | (m) | (m) |
| 2012-10-31 | $1.85M | $127.69M | (m) | $-125.08M | $-1.19M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $-653.68K | (m) | 12 month · $614.91K | (m) | (m) | (m) | (m) |
| 2012-07-31 | $1.84M | $126.27M | (m) | $-123.22M | $-893.07K | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $-779.33K | (m) | 9 month · $111.11K | (m) | (m) | (m) | (m) |
| 2012-04-30 | $1.81M | $125.96M | (m) | $-122.59M | $-338.95K | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $-517.56K | (m) | 6 month · $111.11K | (m) | (m) | (m) | (m) |
| 2012-01-31 | $1.80M | $125.75M | (m) | $-121.72M | $737.96K | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $-104.71K | (m) | 3 month · $80.76K | (m) | (m) | (m) | (m) |
| 2011-10-31 | $1.76M | $125.13M | (m) | $-120.83M | $1.06M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 12 month · $741.98K | (m) | (m) | (m) | (m) |
| 2011-07-31 | $1.72M | $124.35M | (m) | $-118.04M | $2.24M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $-789.03K | (m) | 9 month · $643.02K | (m) | (m) | (m) | (m) |
| 2010-10-31 | $1.54M | $120.10M | (m) | $-113.45M | $4.60M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $1.41M | (m) | 12 month · $743.00K | (m) | (m) | (m) | (m) |
| 2009-10-31 | (m) | (m) | (m) | (m) | $4.45M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CITIUS ONCOLOGY, INC. (CTOR) | United States | $0.097B | -1.49 |
| Milestone Pharmaceuticals Inc. (MIST) | $0.098B | -2.00 | |
| Acrivon Therapeutics, Inc. (ACRV) | United States | $0.091B | -1.03 |
| ProMIS Neurosciences Inc. (PMN) | $0.102B | ||
| Rallybio Corp (RLYB) | United States | $0.089B | |
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| ONCOLYTICS BIOTECH INC (ONCY) | $0.086B | ||
| NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) | United States | $0.086B | |
| Biomea Fusion, Inc. (BMEA) | United States | $0.107B | -3.30 |
| Lexaria Bioscience Corp. (LEXX) | $0.084B | -1.92 |